Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Hugo E . Vargas, M.D.

Back to Research Profile

  1. Gallegos-Orozco JF, Vargas HE. Liver transplantation: from Child to MELD. Med Clin North Am 2009 Jul; 93(4):931-50, ix.
    View PubMed
  2. Silva AC, Evans JM, McCullough AE, Jatoi MA, Vargas HE, Hara AK. MR imaging of hypervascular liver masses: a review of current techniques. Radiographics 2009 Mar-Apr; 29(2):385-402.
    View PubMed
  3. Rodriguez-Torres M, Jeffers LJ, Sheikh MY, Rossaro L, Ankoma-Sey V, Hamzeh FM, Martin P, Latino Study Group. Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. N Engl J Med 2009 Jan 15; 360(3):257-67.
    View PubMed
  4. Rodriguez-Torres M, Jeffers LJ, Sheikh MY, Rossaro L, Ankoma-Sey V, Hamzeh FM, Martin P, for the Latino Study Group. Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. N Engl J Med 2009; 360:257-67.
    View PubMed
  5. Gurudu SR, Vargas HE, Leighton JA. New frontiers in small-bowel imaging: the expanding technology of capsule endoscopy and its impact in clinical gastroenterology. Rev Gastroenterol Disord 2008 Winter; 8(1):1-14.
    View PubMed
  6. Singh V, Rudraraju M, Carey EJ, Byrne TJ, Vargas HE, Williams JE, Balan V, Douglas DD, Rakela J. Severe Hepatotoxicity Caused by a Methasteron-containing, Performance-enhancing Supplement. J Clin Gastroenterol 2008 Sep 22. [Epub ahead of print]
    View PubMed
  7. Gallegos-Orozco JF, Rakela J, Rosati MJ, Vargas HE, Balan V. Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy. Dig Dis Sci 2008 Sep; 53(9):2564-8. Epub 2008 Jul 02.
    View PubMed
  8. Gallegos-Orozco JF, Rakela J, Rosati MJ, Vargas HE, Balan V. Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy. Dig Dis Sci 2008 Sep; 53(9):2564-8. Epub 2008 Jul 02.
    View PubMed
  9. Carey EJ, Vargas HE, Douglas DD, Balan V, Byrne TJ, Harrison ME, Rakela J. Inpatient admissions for drug-induced liver injury: results from a single center. Dig Dis Sci 2008 Jul; 53(7):1977-82. Epub 2008 Apr 05.
    View PubMed
  10. Umphrey LG, Hurst RT, Eleid MF, Lee KS, Reuss CS, Hentz JG, Vargas HE, Appleton CP. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation. Liver Transpl 2008 Jun; 14(6):886-92.
    View PubMed
  11. Mekeel KL, Moss AA, Reddy KS, Douglas DD, Vargas HE, Carey EJ, Byrne TJ, Harrison ME, Rakela J, Mulligan DC. Living donor liver transplantation in polycystic liver disease. Liver Transpl 2008 May; 14(5):680-3.
    View PubMed
  12. Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Blei A, Gulberg V, Sigal S, Teuber P, Terlipressin Study Group. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008 May; 134(5):1360-8. Epub 2008 Feb 13.
    View PubMed
  13. de Franchis R, Eisen GM, Laine L, Fernandez-Urien I, Herrerias JM, Brown RD, Fisher L, Vargas HE, Vargo J, Thompson J, Eliakim R. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology 2008 May; 47(5):1595-603.
    View PubMed
  14. Gurudu SR, Vargas HE, Leighton JA. New frontiers in small-bowel imaging: The expanding technology of capsule endoscopy and its impact in clinical gastroenterology. Rev Gastroenterol Disord 2008; 8(1).
    View PubMed
  15. Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Blei A, Gulberg V, Sigal S, Teuber P, the Terlipressin Study Group. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008; 134:1360-8.
    View PubMed
  16. McCashland T, Watt K, Lyden E, Adams L, Charlton M, Smith AD, McGuire BM, Biggins SW, Neff G, Burton JR Jr, Vargas H, Donovan J, Trotter J, Faust T. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl 2007 Sep; 13(9):1246-53.
    View PubMed
  17. Lee HR, Hurst RT, Vargas HE. Transient left ventricular apical ballooning syndrome (Takotsubo cardiomyopathy) following orthotopic liver transplantation. Liver Transpl 2007 Sep; 13(9):1343-5.
    View PubMed
  18. McCashland T, Watt K, Lyden E, Adams L, Charlton M, Smith AD, McGuire BM, Biggins SW, Neff G, Burton JR Jr, Vargas H, Donovan J, Trotter J, Faust T. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl 2007 Sep; 13(9):1246-53.
    View PubMed
  19. Pasha SF, Harrison ME, Das A, Nguyen CC, Vargas HE, Balan V, Byrne TJ, Douglas DD, Mulligan DC. Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc 2007 Jul; 66(1):44-51.
    View PubMed
  20. Werner T, Vargas HE, Chalasani N. Macro-aspartate aminotransferase and monoclonal gammopathy: a review of two cases. Dig Dis Sci 2007 May; 52(5):1197-8. Epub 2007 Mar 15.
    View PubMed
  21. Cheruvattath R, Rosati MJ, Gautam M, Vargas HE, Rakela J, Balan V. Pegylated interferon and ribavirin failures: is retreatment an option? Dig Dis Sci 2007 Mar; 52(3):732-6.
    View PubMed
  22. Gallegos-Orozco JF, Vargas HE. Should antihepatitis B virus core positive or antihepatitis C virus core positive subjects be accepted as organ donors for liver transplantation? J Clin Gastroenterol 2007 Jan; 41(1):66-74.
    View PubMed
  23. Cheruvattath R, Orrego M, Gautam M, Byrne T, Alam S, Voltchenok M, Edwin M, Wilkens J, Williams JW, Vargas HE. Vitamin A toxicity: when one a day doesn't keep the doctor away. Liver Transpl 2006 Dec; 12(12):1888-91.
    View PubMed
  24. Vargas HE. A difficult case of primary sclerosing cholangitis. Liver Transpl 2006 Nov; 12(11 Suppl 2):S65-7.
    View PubMed
  25. Gallegos-Orozco JF, Arenas JI, Vargas HE, Kibler KV, Wilkinson JK, Nowicki M, Radkowski M, Nasseri J, Rakela J, Laskus T. Selection of different 5' untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection. J Viral Hepat 2006 Jul; 13(7):489-98.
    View PubMed
  26. Orrego M, Vargas HE, Balan V, Wells C, Harrison ME, Larson J, Huettl E, Liu PT. Portal hypertension due to a splenic arteriovenous fistula: a case report. Dig Dis Sci 2006 Jun; 51(6):1113-6.
    View PubMed
  27. Sachdev M, Hernandez JL, Sharma P, Douglas DD, Byrne T, Harrison ME, Mulligan D, Moss A, Reddy K, Vargas HE, Rakela J, Balan V. Liver transplantation in the MELD era: a single-center experience. Dig Dis Sci 2006 Jun; 51(6):1070-8.
    View PubMed
  28. Henderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LJ, Abu-Elmagd K, Connor J, DIVERT Study Group. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 2006 May; 130(6):1643-51.
    View PubMed
  29. Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transpl 2006 Apr; 12(4):560-5.
    View PubMed
  30. Henderson MJ, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LJ, Abu-Elmagd K, Connor J, Vargas HE, DIVERT Study Group. Distal splenorenal shunt versus transjuclar intrhepatic portal systematic shunt for variceal bleeding: A randomized trial. Gastroenterology 2006; 130:1643-51.
    View PubMed
  31. Werner T, Vargas HE, Chalasani N. Macro-aspartate aminotransferase and monoclonal gammopathy: A review of two cases. Dig Dis Sci 2006.
    View PubMed
  32. Rodriguez-Luna H, Vargas HE, Moss A, Reddy KS, Freeman RB, Mulligan D. Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant 2005 Sep; 5(9):2244-7.
    View PubMed
  33. Orrego M, Guo LS, Reeder C, De Petris G, Balan V, Douglas DD, Byrne T, Harrison E, Mulligan D, Rodriguez-Luna H, Moss A, Reddy K, Rakela J, Vargas HE. Hepatic B-cell non-Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infection. Liver Transpl 2005 Jul; 11(7):796-9.
    View PubMed
  34. Rodriguez-Luna H, Vargas HE, Byrne T, Rakela J. Artificial neural network and tissue genotyping of hepatocellular carcinoma in liver-transplant recipients: prediction of recurrence. Transplantation 2005 Jun 27; 79(12):1737-40.
    View PubMed
  35. Rodriguez-Luna H, Vargas HE. Management of hepatitis C virus infection in the setting of liver transplantation. Liver Transpl 2005 May; 11(5):479-89.
    View PubMed
  36. Gallegos-Orozco JF, Vargas HE, Rakela J. Virologically compromised donor grafts in liver transplantation. J Hepatol 2004 Oct; 41(4):512-21.
    View PubMed
  37. Arenas JI, Vargas HE. Hepatitis C virus antiviral therapy in patients with cirrhosis. Gastroenterol Clin North Am 2004 Sep; 33(3):549-62, ix.
    View PubMed
  38. Rodriguez-Luna H, Balan V, Sharma P, Byrne T, Mulligan D, Rakela J, Vargas HE. Hepatitis C virus infection with hepatocellular carcinoma: Not a controversial indication for liver transplantation. Transplantation 2004 Aug 27; 78(4):580-3.
    View PubMed
  39. Rodriguez-Luna H, Vargas HE, Williams J, De Petris G, Rakela J, Douglas DD. Primary biliary cirrhosis and systemic amyloidosis, a new association. Dig Dis Sci 2004 Aug; 49(7-8):1196-200.
    View PubMed
  40. Arenas JI, Gallegos-Orozco JF, Laskus T, Wilkinson J, Khatib A, Fasola C, Adair D, Radkowski M, Kibler KV, Nowicki M, Douglas D, Williams J, Netto G, Mulligan D, Klintmalm G, Rakela J, Vargas HE. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. J Infect Dis 2004 Jun 1; 189(11):2037-46.
    View PubMed
  41. Carey EJ, Douglas DD, Balan V, Vargas HE, Byrne TJ, Moss AA, Mulligan DC. Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: a single-center experience. Liver Transpl 2004 Apr; 10(4):529-33.
    View PubMed
  42. Rodriguez-Luna H, Vargas HE. Natural history of hepatitis C and outcomes following liver transplantation. Minerva Gastroenterol Dietol 2004 Mar; 50(1):51-9.
    View PubMed
  43. Rodriguez-Luna H, Khatib A, Sharma P, De Petris G, Williams JW, Ortiz J, Hansen K, Mulligan D, Moss A, Douglas DD, Balan V, Rakela J, Vargas HE. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha 2b and ribavirin: An open-label series. Transplantation 2004 Jan 27; 77(2):190-4.
    View PubMed
  44. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH. Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transpl 2004 Jan; 10(1):36-41.
    View PubMed
  45. Sharma P, Balan V, Hernandez J, Rosati M, Williams J, Rodriguez-Luan H, Schwartz J, Harrison E, Anderson M, Byrne T, Vargas HE, Douglas DD, Rakela J. Hepatic steatosis in hepatitis C virus genotype 3 infection: Does it correlate with body mass index, fibrosis, and HCV risk factors? Dig Dis Sci 2004 Jan; 49(1):25-9.
    View PubMed
  46. Rodriguez-Luna H, Vargas HE, Sharma P, Ortiz J, De Petris G, Balan V, Byrne T, Moss A, Mulligan D, Rakela J, Douglas DD. Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci 2004 Jan; 49(1):38-41.
    View PubMed
  47. Fontana RJ, Everson GT, Tuteja S, Vargas HE, Shiffman ML. Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis. Clin Gastroenterol Hepatol 2004; 2:183-197.
    View PubMed
  48. Gallegos-Orozco JF, Vargas HE. Recurrent hepatitis C virus alter liver transplantation: the role of quasispecies complexity and diversity. Curr Opin Organ Transplant 2004; 9:99-103.
  49. Chopra KB, Demetris AJ, Blakolmer K, Dvorchik I, Laskus T, Wang LF, Araya VR, Dodson F, Fung JJ, Rakela J, Vargas HE. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation 2003 Nov 27; 76(10):1487-91.
    View PubMed
  50. Arenas JI, Vargas HE, Rakela J. The use of hepatitis C-infected grafts in liver transplantation. Liver Transpl 2003 Nov; 9(11 Suppl 3):S48-S51.
    View PubMed
  51. Shiffman ML, Vargas HE, Everson GT. Controversies in the management of hepatitis C virus infection after liver transplantation. Liver Transpl 2003 Nov; 9(11):1129-44.
    View PubMed
  52. Rodriguez-Luna H, Arenas J, Vargas HE. The use of virologically compromised organs in liver transplantation. Clin Liver Dis 2003 Aug; 7(3):573-84, vi.
    View PubMed
  53. Vargas HE, Laskus T, Radkowski M, Wilkinson J, Balan V, Douglas DD, Harrison ME, Mulligan DC, Olden K, Adair D, Rakela J. Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl 2002 Nov; 8(11):1014-9.
    View PubMed
  54. Rakela J, Vargas HE. Hepatitis C: Magnitude of the problem. Liver Transpl 2002 Oct; 8(10 Suppl 1):S3-6.
    View PubMed
  55. Joya-Vazquez PP, Dodson FS, Dvorchik I, Gray E, Chesky A, Demetris AJ, Shakil O, Fung JJ, Vargas HE. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation 2002 May 27; 73(10):1598-602.
    View PubMed
  56. Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J. The origin of hepatitis C virus reinfecting transplanted livers: Serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis 2002 Feb 15; 185(4):417-21.
    View PubMed
  57. Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, Rakela J, Laskus T. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: Evidence of replication. J Virol 2002 Jan; 76(2):600-8.
    View PubMed
  58. Vargas HE, Dodson FS, Rakela J. A concise update on the status of liver transplantation for hepatitis B virus: The challenges in 2002. Liver Transpl 2002 Jan; 8(1):2-9.
    View PubMed
  59. Arenas JI Fasola CG Rakela J Wilkinson JK, Laskus T, Vargas H, Klintmalm G. Analysis Of 5’UTR And E2 Region Quasispecies In Liver Transplantation. Gastroenterology 2002; 123:80.
    View PubMed
  60. Ahmad J, Vargas H, Balan V, Rakela J, Shakil AO. A randomized, double-blind, placebo-controlled trial of interferon-alpha and amantidine versus interferon-alpha alone in the treatment of patients with chronic hepatitis C. Dig Dis Sci 2002; 47(7):1655-6.
    View PubMed
  61. Kashyap R, Jain A, Nalesnik M, Carr B, Barnes J, Vargas HE, Rakela J, Fung J. Clinical significance of elevated alpha-fetoprotein in adults and children. Dig Dis Sci 2001 Aug; 46(8):1709-13.
    View PubMed
  62. Laskus T, Wang LF, Radkowski M, Vargas H, Nowicki M, Wilkinson J, Rakela J. Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain. J Virol 2001 Mar; 75(5):2059-66.
    View PubMed
  63. Vargas HE. The real danger of lamivudine-resistant hepatitis B virus infection in the immunocompromised host. Liver Transpl 2001 Mar; 7(3):279-81.
    View PubMed
  64. Kashyap R, Jain A, Nalesnik M, Carr B, Barnes J, Rakela J, Vargas HE, Fung J. Clinical Significance Of Elevated ?Ñ-Feto Protein In Adults And Children. Digest Dis Sci 2001; 46:1709-1713.
    View PubMed
  65. Paterson DL, Gayowski T, Wannstedt CF, Wagener MM, Marino IR, Vargas H, Laskus T, Rakela J, Singh, N. Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virus hepatitis. Clin Transplant 2000; 14(1):48-54.
    View PubMed
  66. Gayowski, T, Singh, N, Keyes L, Wannstedt CF, Wagener MM, Vargas HE, Laskus T, Rakela J, Fung JJ, Marino IR. Late-onset renal failure after liver transplantation: role of posttransplant alcohol use. Transplantation 2000; 69(3):383-8.
    View PubMed
  67. De Vera ME, Reyes J, Mazariegos G, Schaefer N, Vargas H, Bond G, Wu T, Fung J, Starzl TE, Abu-Elmagd K. Isolated intestinal versus composite visceral allografts: causes of graft failure. Transplant Proc 2000; 32:1221-2.
    View PubMed
  68. Taniguchi M, Shakil AO, Vargas HE, Laskus T, Demetris AJ, Gayowski T, Dodson SF, Fung JJ, Rakela J. Clinical and virological response of hepatitis B and C viral co-infection after liver transplantation: effect of viral hepatitis D. Liver Transpl Surg 2000; 6(1):92-6.
  69. Vargas HE, Whitcomb DC. Hepatitis C For Half A Century. Gastroenterology 2000; 119:1405-1407.
    View PubMed
  70. Vargas HE, Laskus T, Wang LF, Lee R, Radkowski M, Dodson F, Fung JJ, Rakela J. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999 Jul; 117(1):149-53.
    View PubMed
  71. Vargas HE, Rakela J. Liver transplantation for variceal hemorrhage. Gastrointest Endosc Clin N Am 1999 Apr; 9(2):347-53.
    View PubMed
  72. Radkowski M, Wang LF, Vargas H, Rakela J, Laskus T. Hepatitis C virus in peripheral blood mononuclear cells from a chronically infected patient receiving liver graft from infected donor. Transplantation 1999 Feb 27; 67(4):627-9.
    View PubMed
  73. Vargas HE, Gerber D, Abu-Elmagd K. Management of portal hypertension-related bleeding. Surg Clin North Am 1999 Feb; 79(1):1-22.
    View PubMed
  74. Chopra K, Vargas H, Demetris A, Blakolmer K, Dvorchick I, Laskus T, Wang LF, Araya V, Dodson F, Fung J, Rakela J. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation: a final report. Hepatology 1999; 30(4):331.
  75. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative- strand viral RNA in various tissues. Hepatology 1998 Nov; 28(5):1398-401.
    View PubMed
  76. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1. J Infect Dis 1998 Oct; 178(4):1189-92.
    View PubMed
  77. Radkowski M, Wang LF, Vargas HE, Rakela J, Laskus T. Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. Transplantation 1998 Sep 15; 66(5):664-6.
    View PubMed
  78. Laskus T, Radkowski M, Wang LF, Jang SJ, Vargas H, Rakela J. Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology 1998 Aug 15; 248(1):164-71.
    View PubMed
  79. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Detection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR. J Virol 1998 Apr; 72(4):3072-5.
    View PubMed
  80. Laskus T, Radkowski M, Nowicki M, Wang LF, Vargas H, Rakela J. Association between hepatitis B virus core promoter rearrangements and hepatocellular carcinoma. Biochem Biophys Res Commun 1998 Mar 27; 244(3):812-4.
    View PubMed
  81. Radkowski M, Wang LF, Vargas H, Rakela J, Laskus T. Lack of evidence for GB virus C/hepatitis G virus replication in peripheral blood mononuclear cells. J Hepatol 1998 Feb; 28(2):179-83.
    View PubMed
  82. Vargas HE, Laskus T, Wang LF, Radkowski M, Poutous A, Lee R, Demetris JA, Gayowski T, Marino IR, Singh N, Dodson F, Casavilla A, Fung JJ, Rakela J. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 1998 Jan; 4(1):22-7.
    View PubMed
  83. Laskus T, Wang LF, Radkowski M, Jang SJ, Vargas H, Dodson F, Fung J, Rakela J. Hepatitis G virus infection in American patients with cryptogenic cirrhosis: no evidence for liver replication. J Infect Dis 1997 Dec; 176(6):1491-5.
    View PubMed
  84. Wang LF, Radkowski M, Vargas H, Rakela J, Laskus T. Amplification and fusion of long fragments of hepatitis C virus genome. J Virol Methods 1997 Nov; 68(2):217-23.
    View PubMed
  85. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol 1997 Oct; 71(10):7804-6.
    View PubMed
  86. Vargas HE, Laskus T, Radkowski M, Poutous A, Wang LF, Lee R, Dodson F, Gayowski T, Singh N, Marino IR, Fung JJ, Zhang-Keck ZY, Kim JP, Rakela J. Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients. Transplantation 1997 Sep 15; 64(5):786-8.
    View PubMed
  87. Gayowski T, Singh N, Marino IR, Vargas H, Wagener M, Wannstedt C, Morelli F, Laskus T, Fung JJ, Rakela J, Starzl TE. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997 Aug 15; 64(3):422-6.
    View PubMed
  88. Laskus T, Wang LF, Radkowski M, Vargas H, Cianciara J, Poutous A, Rakela J. Comparison of hepatitis B virus core promoter sequences in peripheral blood mononuclear cells and serum from patients with hepatitis B. J Gen Virol 1997 Mar; 78(Pt 3):649-53.
    View PubMed
  89. Vargas HE, Wang LF, Laskus T, Poutous A, Lee R, Demetris A, Dodson F, Casavilla A, Fung J, Gayowski T, Singh N, Marino I, Rakela J. Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation center. J Infect Dis 1997 Feb; 175(2):448-50.
    View PubMed
  90. Vargas H, Laskus T, Radkowski M, Poutous A, Wang LF, Lee R, Dodson F, Gayowski T, Singh N, Marino I, Fung J, Zhang-Keck Z, Kim J, Rakela J. Hepatitis G Virus Co-infection In HCV- Infected Liver Transplant Recipients. Transplantation 1997; 64(5):786-788.
    View PubMed
  91. Laskus T, Wang LF, Radkowski M, Jang SJ, Vargas H, Dodson F, Fung J, Rakela J. Hepatitis G Virus In American Patients With Cryptogenic Cirrhosis: No Evidence For Liver Replication. J Infect Dis 1997; 176(6):1491-1495.
    View PubMed
  92. Laskus T, Wang LF, Rakela J, Vargas H, Pinna AD, Tsamandas AC, Demetris AJ, Fung J. Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology 1996 Jun 1; 220(1):171-6.
    View PubMed
  93. DiSario JA, Burt RW, Vargas H, McWhorter WP. Small bowel cancer: epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol 1994 May; 89(5):699-701.
    View PubMed
  94. Hubbell HR, Vargas HE, Tsujimoto KL, Gibson GD, Pequignot EC, Bigler RD, Carter WA, Strayer DR. Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft. Cancer Immunol Immunother 1992; 35(3):151-7.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.